1、REFINITIV STREETEVENTSEDITED TRANSCRIPTPFE.N-Q2 2025 Pfizer Inc Earnings CallEVENT DATE/TIME:AUGUST 05,2025/2:00PM GMTOVERVIEW:Company SummaryREFINITIV STREETEVENTS|Contact Us2025 Refinitiv.All rights reserved.Republication or redistribution of Refinitiv content,including by framing or similar means

2、,is prohibited without the prior writtenconsent of Refinitiv.Refinitiv and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.CORPORATE PARTICIPANTSFrancesca DeMartino Pfizer Inc-Chief Investor Relations Officer,Senior Vice PresidentAlbert Bourla Pfizer Inc-Chairm

3、an of the Board,Chief Executive OfficerDavid Denton Pfizer Inc-Executive Vice President,Chief Financial OfficerAamir Malik Pfizer Inc-Executive Vice President,Chief US Commercial OfficerChris Boshoff Pfizer Inc-Chief Scientific Officer,President-Research&DevelopmentAlexandre De Germay Pfizer Inc-Exe

4、cutive Vice President,Chief International Commercial OfficerAndrew Baum Pfizer Inc-Executive Vice President,Chief Strategy and Innovation OfficerCONFERENCE CALL PARTICIPANTSTrung Huynh UBS Equities-AnalystChristopher Schott JPMorgan-AnalystAlexandria Hammond Wolfe Research LLC-AnalystMohit Bansal We

5、lls Fargo Securities LLC-AnalystCourtney Breen Bernstein Research-AnalystDavid Risinger Leerink Partners-AnalystKerry Holford Berenberg-AnalystEvan Seigerman BMO Capital Markets-AnalystCarter Gould Cantor Fitzgerald-AnalystAsad Haider Goldman Sachs-AnalystUmer Raffat Evercore ISI-AnalystRajesh Kumar

6、 HSBC-AnalystTimothy Anderson BofA Global Research-AnalystSteve Scala TD Cowen-AnalystTerence Flynn Morgan Stanley-AnalystPRESENTATIONOperatorGood day,everyone,and welcome to Pfizers second-quarter 2025 earnings conference call.Todays call is being recorded.At this time,I wouldlike to turn the call